e-learning
resources
London 2016
Sunday, 04.09.2016
Molecular targets in pulmonary disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Targeting the hippo effector YAP overcomes the de novo and acquired resistances to EGFR-TKI in lung adenocarcinoma
Chaeuk Chung (Daejeon, Republic of Korea), Chaeuk Chung, Dahye Lee, Ju Ock Kim, Sun Young Kim, Jeong Eun Lee, Jea Young Moon, Yeon Hee Park, Sung Soo Jung, Dong Il Park
Source:
International Congress 2016 – Molecular targets in pulmonary disease
Session:
Molecular targets in pulmonary disease
Session type:
Thematic Poster
Number:
886
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Chaeuk Chung (Daejeon, Republic of Korea), Chaeuk Chung, Dahye Lee, Ju Ock Kim, Sun Young Kim, Jeong Eun Lee, Jea Young Moon, Yeon Hee Park, Sung Soo Jung, Dong Il Park. Targeting the hippo effector YAP overcomes the de novo and acquired resistances to EGFR-TKI in lung adenocarcinoma. Eur Respir J 2016; 48: Suppl. 60, 886
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Comprehensive analysis of the PTEN domains on TGFbeta-induced aberrant cell motility in lung alveolar/epithelial cells by using PTEN constructs with deletion mutants
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Translocation of beta-catenin into cytoplasm during TGFbeta-induced EMT is negatively regulated by phosphorylation of the PTEN C-terminus in lung cancers
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Role of hypoxia in epithelial-to-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
RBM5 overexpression reverses acquired resistance to gefitinib in PC9/AB2 NSCLC cells
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016
The effect of compensatory induction of various PTEN mutants against TGFbeta-induced translocation of beta-catenin in lung cancer cells
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Aromatase inhibition alters the mechanical properties of non small-cell lung cancer cells affecting cell movement
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Expression of the ILK-PINCH-PARVIN (IPP) complex and its binding partner Rsu-1 in human non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
Neurotrophin TrkB receptor mediates the epithelial to mesenchymal transition in lung adenocarcinoma cells
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Molecular mechanisms of inhibition of lung cancer stem cells invasion by a novel soy isoflavone VF166
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Immunohistochemistry
versus
DNA testing for detection of
EGFR
mutations and
ALK
rearrangements in lung adenocarcinoma patients
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Methylation associated pathway activity deregulation in lung adenocarcinoma
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014
Surface expression of CTLA-4 on CD4/CD25
high
cells in lung cancer
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Targeting the mTOR signaling pathway to inhibit lung cell senescence in COPD
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
INTS12 knockdown leads to perturbation of genes and pathways of relevance to airway biology
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015
Surface vs. intracellular CTLA-4 expression in lung cancer
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Expression and clinical implications of the estrogen receptor β in lung adenocarcinoma
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Molecular mechanisms of pirfenidone activity in human lung fibroblasts
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept